Advances in brain stimulation for depression

Annals of Clinical Psychiatry

Volumn 25, Issue 3, 2013, Pages 217-224

  Wani, Anna ^a   Trevino, Kenneth ^a   Marnell, Paige ^a   Husain, Mustafa M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Deep brain stimulation; Magnetic seizure therapy; Neurostimulation; Transcranial magnetic stimulation; Treatment resistant depression; Vagus nerve stimulation

Indexed keywords

ANTIDEPRESSANT AGENT;

ANTIDEPRESSANT ACTIVITY; BRAIN DEPTH STIMULATION; DEPRESSION; ELECTROCONVULSIVE THERAPY; HAMILTON SCALE; HUMAN; INTRACTABLE EPILEPSY; MAGNETIC FIELD; MAGNETIC SEIZURE THERAPY; MAJOR DEPRESSION; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SEIZURE THRESHOLD; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; VAGUS NERVE STIMULATION; VOICE CHANGE;

DEEP BRAIN STIMULATION; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ELECTROCONVULSIVE THERAPY; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 84886899347     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602. (Pubitemid 40973434)
2. Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry. 2002;63:963-971. (Pubitemid 35388053)
3. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105. (Pubitemid 37432885)
4. World Health Organization. The world health report 2001. Mental health: new understanding, new hope. Geneva, Switzerland: World Health Organization; 2001.
5. Greenberg P E, Stiglin LE, Finkelstein SN, et al. The economic burden of depression in 1990. J Clin Psychiatry. 1993;54:405-418. (Pubitemid 24020594)
6. Stewart WF, Ricci JA, Chee E, et al. Cost of lost productive work time among US workers with depression. JAMA. 2003;289:3135-3144. (Pubitemid 37432889)
7. Greenberg P, Corey-Lisle PK, Birnbaum H, et al. Economic implications of treatment-resistant depression among employees. Pharmacoeconomics. 2004;22:363-373. (Pubitemid 38609813)
8. Berlim MT, Turecki G. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol. 2007;17:696-707. (Pubitemid 47422400)
9. Ananth J. Treatment-resistant depression. Psychother Psychosom. 1998;67:61-70. (Pubitemid 28132531)
10. Berlim MT, Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry. 2007;52:46-54. (Pubitemid 46743497)
11. Bird D, Haddad PM, Dursun SM. An overview of the definition and management of treatmentresistant depression. Klinik Psikofarmakoloji Bulteni. 2002;12:92-101. (Pubitemid 34764424)
12. Janicak PG, Dowd SM. Treatment-resistant depression: an update on diagnosis and management. Psychopharm Review. 2009;44:41-48.
13. Keller MB. Issues in treatment-resistant depression. J Clin Psychiatry. 2005;66(suppl 8):5-12. (Pubitemid 43004170)
14. Rush AJ, Thase ME, Dubé S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry. 2003;53:743-753. (Pubitemid 39658488)
15. Berman RM, Narasimhan M, Charney DS. Treatment-refractory depression: definitions and characteristics. Depress Anxiety. 1997;5:154-164. (Pubitemid 28082224)
16. Souery D, Amsterdam JD, De Montigny C, et al. Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol. 1999;9:83-91. (Pubitemid 29073687)
17. Petersen TJ, Papakostas GI, Posternak MA, et al. Empirical testing of two models for staging antidepressant treatment resistance. J Clin Psychopharmacol. 2005;25:336-341. (Pubitemid 41060253)
18. Fekadu A, Wooderson SC, Donaldson C, et al. A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. J Clin Psychiatry. 2009;70:177-184.
19. Nierenberg AA, Husain MM, Trivedi MH, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR D report. Psychol Med. 2010;40:41-50.
20. O'Reardon JP, Amsterdam JD. Treatment-resistant depression: progress and limitations. Psychiatric Annals. 1998;28:633-640.
21. Souery D, Van Der Auwera K. The multiple facets of treatment-resistant depression. CNS Spectr. 2004;9:803-807. (Pubitemid 39602936)
22. Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17:244-253. (Pubitemid 33131305)
23. Sackeim HA, Prudic J, Devanand D P, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57:425-434. (Pubitemid 30257256)
24. Sobin C, Sackeim HA, Prudic J, et al. Predictors of retrograde amnesia following ECT. Am J Psychiatry. 1995;152:995-1001.
25. ™ Model 105 Generator. Houston, TX: Cyberonics, Inc; 2011-2012.
26. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25:713-728. (Pubitemid 32995954)
27. Harden CL, Pulver MC, Ravdin LD, et al. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav. 2000;1:93-99.
28. Sackeim HA. Vagus nerve stimulation. In: Lisanby SH, ed. Brain stimulation in psychiatric treatment. Washington, DC: American Psychiatric Publishing; 2004:99-142.
29. Henry TR, Bakay RA, Votaw JR, et al. Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia. 1998;39:983-990. (Pubitemid 28413418)
30. Schlaepfer TE. Brain stimulation in depression. In: Griez EJL, Faravelli C, Nutt D, et al, eds. Mood disorders: clinical management and research issues. Chichester, United Kingdom: John Wiley & Sons; 2005:403-425.
31. Ben-Menachem E, Hamberger A, Hedner T, et al. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res. 1995;20:221-227.
32. Walker BR, Easton A, Gale K. Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia. 1999;40:1051-1057. (Pubitemid 29372617)
33. Carpenter LL. Neurostimulation in resistant depression. J Psychopharmacol. 2006;20:35-40. (Pubitemid 44605931)
34. Marangell LB, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry. 2002;51:280-287. (Pubitemid 34214993)
35. George MS, Rush AJ, Marangell LB, et al. A oneyear comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry. 2005;58:364-373. (Pubitemid 41219704)
36. Wassermann EM, Zimmermann T. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther. 2012;133:98-107.
37. Rossi S, Hallett M, Rossini PM, et al; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120:2008-2039.
38. Loo C. Cognitive outcomes in electroconvulsive therapy: optimizing current clinical practice and researching future strategies. J ECT. 2008;24:1-2. (Pubitemid 351498634)
39. Janicak PG, O'Reardon J P, Sampson SM, et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry. 2008;69:222-232. (Pubitemid 351469265)
40. Wasserman E, Epstein CM, Ziemann U, et al, eds. The Oxford handbook of transcranial stimulation. Oxford, United Kingdom: Oxford University Press; 2008:747.
41. McDonald WM, Durkalski V, Ball ER, et al. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety. 2011;28:973-980.
42. George MS, Wassermann EM, Williams WA, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 1995;6:1853-1856.
43. Slotema CW, Blom JD, Hoek HW, et al. Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry. 2010;71:873-884.
44. O'Reardon J P, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208-1216. (Pubitemid 350060890)
45. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67:507-516.
46. Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol. 2008;11:131-147.
47. Lisanby SH, Morales O, Payne N, et al. New developments in electroconvulsive therapy and magnetic seizure therapy. CNS Spectr. 2003;8:529-536. (Pubitemid 38418386)
48. Hömberg V, Netz J. Generalised seizures induced by transcranial magnetic stimulation of motor cortex. Lancet. 1989;2:1223. (Pubitemid 19275481)
49. Lisanby SH, Luber B, Schlaepfer TE, et al. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized withinsubject comparison with electroconvulsive therapy. Neuropsychopharmacology. 2003;28:1852-1865. (Pubitemid 41070851)
50. White PF, Amos Q, Zhang Y, et al. Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesth Analg. 2006;103:76-80. (Pubitemid 44036035)
51. Rowny SB, Benzl K, Lisanby SH. Translational development strategy for magnetic seizure therapy. Exp Neurol. 2009;219:27-35.
52. Kayser S, Bewernick BH, Grubert C, et al. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res. 2011;45:569-576.
53. Lisanby SH, Schlaepfer TE, Fisch HU, et al. Magnetic seizure therapy of major depression. Arch Gen Psychiatry. 2001;58:303-305. (Pubitemid 32209685)
54. Kirov G, Ebmeier K P, Scott AI, et al. Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry. 2008;193:152-155.
55. Hoy KE, Fitzgerald PB. Introducing magnetic seizure therapy: a novel therapy for treatment resistant depression. Aust N Z J Psychiatry. 2010;44:591-598.
56. Kuehn BM. Scientists probe deep brain stimulation: some promise for brain injury, psychiatric illness. JAMA. 2007;298:2249-2251. (Pubitemid 350146233)
57. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651-560.
58. Schlaepfer TE, Lieb K. Deep brain stimulation for treatment of refractory depression. Lancet. 2005;366:1420-1422. (Pubitemid 41483800)
59. Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. New Engl J Med. 1999;340:1476-1480. (Pubitemid 29220547)
60. Stefurak T, Mikulis D, Mayberg H, et al. Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study. Mov Disord. 2003;18:1508-1516.
61. Kennedy SH, Giacobbe P, Rizvi SJ, et al. Deep brain stimulation for treatment-resistant depression: followup after 3 to 6 years. Am J Psychiatry. 2011;168:502-510.
62. Loo CK, Martin DM. Could transcranial direct current stimulation have unexpected additional benefits in the treatment of depressed patients? Expert Rev Neurother. 2012;12:751-753.
63. Bindman LJ, Lippold OC, Redfearn JW. The action of brief polarizing currents on the cerebral cortex of the rat (1) during current flow and (2) in the production of long-lasting after-effects. J Physiol. 1964;172:369-382.
64. Nitsche MA, Cohen LG, Wassermann EM, et al. Transcranial direct current stimulation: state of the art 2008. Brain Stimul. 2008;1:206-223.